Healthcare & Life Sciences
Deka Biosciences
series-b
series-b
Stage
1
Investors
About
Deka Biosciences develops disease-specific therapeutic constructs called Diakines™, which combine dual and complementary cytokines to enhance targeted delivery and immune modulation in affected tissues.
Explore Deka Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.